NM_145046.5:c.820G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_145046.5(CALR3):​c.820G>A​(p.Val274Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0125 in 1,614,166 control chromosomes in the GnomAD database, including 1,058 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 140 hom., cov: 33)
Exomes 𝑓: 0.011 ( 918 hom. )

Consequence

CALR3
NM_145046.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.36

Publications

13 publications found
Variant links:
Genes affected
CALR3 (HGNC:20407): (calreticulin 3) The protein encoded by this gene belongs to the calreticulin family, members of which are calcium-binding chaperones localized mainly in the endoplasmic reticulum. This protein is also localized to the endoplasmic reticulum lumen, however, its capacity for calcium-binding may be absent or much lower than other family members. This gene is specifically expressed in the testis, and may be required for sperm fertility. Mutation in this gene has been associated with familial hypertrophic cardiomyopathy. [provided by RefSeq, Dec 2011]
CALR3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030251443).
BP6
Variant 19-16482548-C-T is Benign according to our data. Variant chr19-16482548-C-T is described in ClinVar as [Benign]. Clinvar id is 192183.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0804 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CALR3NM_145046.5 linkc.820G>A p.Val274Ile missense_variant Exon 7 of 9 ENST00000269881.8 NP_659483.2 Q96L12A0A140VJF7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CALR3ENST00000269881.8 linkc.820G>A p.Val274Ile missense_variant Exon 7 of 9 1 NM_145046.5 ENSP00000269881.3 Q96L12
ENSG00000141979ENST00000409035.1 linkn.*623G>A non_coding_transcript_exon_variant Exon 10 of 12 2 ENSP00000386951.2 B8ZZF3
ENSG00000141979ENST00000409035.1 linkn.*623G>A 3_prime_UTR_variant Exon 10 of 12 2 ENSP00000386951.2 B8ZZF3
CALR3ENST00000602234.1 linkn.494G>A non_coding_transcript_exon_variant Exon 3 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0267
AC:
4065
AN:
152168
Hom.:
136
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0528
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0835
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.0302
Gnomad SAS
AF:
0.00725
Gnomad FIN
AF:
0.00377
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00429
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0347
AC:
8722
AN:
251488
AF XY:
0.0264
show subpopulations
Gnomad AFR exome
AF:
0.0514
Gnomad AMR exome
AF:
0.189
Gnomad ASJ exome
AF:
0.00377
Gnomad EAS exome
AF:
0.0246
Gnomad FIN exome
AF:
0.00365
Gnomad NFE exome
AF:
0.00429
Gnomad OTH exome
AF:
0.0248
GnomAD4 exome
AF:
0.0110
AC:
16047
AN:
1461880
Hom.:
918
Cov.:
46
AF XY:
0.00986
AC XY:
7174
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.0534
AC:
1789
AN:
33478
American (AMR)
AF:
0.175
AC:
7808
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00425
AC:
111
AN:
26136
East Asian (EAS)
AF:
0.0237
AC:
941
AN:
39700
South Asian (SAS)
AF:
0.00512
AC:
442
AN:
86258
European-Finnish (FIN)
AF:
0.00399
AC:
213
AN:
53418
Middle Eastern (MID)
AF:
0.00971
AC:
56
AN:
5768
European-Non Finnish (NFE)
AF:
0.00351
AC:
3908
AN:
1112006
Other (OTH)
AF:
0.0129
AC:
779
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
995
1990
2984
3979
4974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0269
AC:
4089
AN:
152286
Hom.:
140
Cov.:
33
AF XY:
0.0274
AC XY:
2041
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0530
AC:
2201
AN:
41564
American (AMR)
AF:
0.0842
AC:
1288
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3470
East Asian (EAS)
AF:
0.0305
AC:
158
AN:
5182
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4822
European-Finnish (FIN)
AF:
0.00377
AC:
40
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00429
AC:
292
AN:
68016
Other (OTH)
AF:
0.0269
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
202
404
606
808
1010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0128
Hom.:
265
Bravo
AF:
0.0368
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.0497
AC:
219
ESP6500EA
AF:
0.00593
AC:
51
ExAC
AF:
0.0301
AC:
3657
Asia WGS
AF:
0.0280
AC:
97
AN:
3478
EpiCase
AF:
0.00338
EpiControl
AF:
0.00362

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Hypertrophic cardiomyopathy 19 Benign:3
Oct 03, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Aug 17, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The CALR3 c.820G>A (p.Val274Ile) variant involves the alteration of a non-conserved nucleotide. 5/5 in silico tools predict benign outcome for this variant. This variant was found in 3671/123152 control chromosomes (320 homozygotes) from ExAC and literature, predominantly observed in the Latino subpopulation at a frequency of 0.214458 (2483/11578). This frequency is about 8578 times the estimated maximal expected allele frequency of a pathogenic CALR3 variant (0.000025), thus this is a common benign polymorphism found primarily in the populations of Latino origin. In addition, multiple clinical diagnostic laboratories/reputable databases in ClinVar have classified this variant as benign. To our knowledge, this variant has not been reported in affected individuals in literature. Taken together, this variant is classified as benign. -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cardiovascular phenotype Benign:1
Oct 03, 2012
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.019
DANN
Benign
0.75
DEOGEN2
Benign
0.070
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.29
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.52
N
PhyloP100
-1.4
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.87
N
REVEL
Benign
0.035
Sift
Benign
0.23
T
Sift4G
Benign
0.23
T
Polyphen
0.0090
B
Vest4
0.029
MPC
0.12
ClinPred
0.00074
T
GERP RS
-3.0
Varity_R
0.024
gMVP
0.082
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12459238; hg19: chr19-16593359; COSMIC: COSV107207096; API